1. Röder, Annika, Hüsken, Saskia, Hutter, Michael C, Wiek, Constanze, Girhard, Marco. 2023. Spotlight on CYP4B1. In International journal of molecular sciences, 24, . doi:10.3390/ijms24032038. https://pubmed.ncbi.nlm.nih.gov/36768362/
2. Yu, Shuyong, Chen, Zhuang, Cheng, Jiajia, Zhong, Ping, Song, Jian. 2022. Case-control study on CYP4B1 gene polymorphism and susceptibility to gastric cancer in the chinese Han population. In BMC medical genomics, 15, 223. doi:10.1186/s12920-022-01367-w. https://pubmed.ncbi.nlm.nih.gov/36307788/
3. Yang, Ling, Yu, Xueyuan, Liu, Meng, Cao, Yang. 2023. A comprehensive analysis of biomarkers associated with synovitis and chondrocyte apoptosis in osteoarthritis. In Frontiers in immunology, 14, 1149686. doi:10.3389/fimmu.2023.1149686. https://pubmed.ncbi.nlm.nih.gov/37545537/
4. Liu, Xiaoling, Jia, Yichen, Shi, Changyuan, Wei, Anjie, Wang, Dan. 2021. CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma. In PloS one, 16, e0247020. doi:10.1371/journal.pone.0247020. https://pubmed.ncbi.nlm.nih.gov/33592039/
5. Yin, Yanhai, Tong, Liangqian, Wan, Zhenling, Huang, Qian, Zhao, Xinhan. 2023. CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: a case-control study. In BMC cancer, 23, 1177. doi:10.1186/s12885-023-11477-y. https://pubmed.ncbi.nlm.nih.gov/38041008/
6. Hsu, H, Rainov, N G, Quinones, A, Sakamoto, K M, Spear, M A. . Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter. In Anticancer research, 23, 2723-8. doi:. https://pubmed.ncbi.nlm.nih.gov/12894565/
7. Rainov, N G, Sena-Esteves, M, Fraefel, C, Chiocca, E A, Breakefield, X O. . A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma. In Advances in experimental medicine and biology, 451, 393-403. doi:. https://pubmed.ncbi.nlm.nih.gov/10026902/
智鼠故事 
